| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief R&D Officer | COO, CSO | Vice President
1 company
Cavanagh William is a Chief R&D Officer at Perspective Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 1 sell.
Estimated insider holdings value: $83K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2020 | CATX Perspective Therapeutics, Inc. | Chief R&D Officer | Buy | 7,692 | $0.52 | $3,999.84 | +38.5% | |
| Nov 15, 2019 | CATX Perspective Therapeutics, Inc. | Chief R&D Officer | Buy | 10,000 | $0.39 | $3,900.00 | +100.0% | |
| Nov 16, 2018 | CATX Perspective Therapeutics, Inc. | COO, CSO | Buy | 10,000 | $0.40 | $4,000.00 | New | |
| Apr 2, 2015 | CATX Perspective Therapeutics, Inc. | Vice President | Sale+OE | 13,340 | $1.53 | $20,410.20 | -100% |